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Abstract
Cardiac fibroblasts produce and degrade extracellular matrix and are critical in regulating cardiac
remodeling and hypertrophy. Fibroblasts are activated by factors such as transforming growth factor
β and inhibited by agents that elevate 3′,5′-cyclic adenosine monophosphate (cAMP) levels. cAMP
signal generation and response is known to be compartmentalized in many cell types in part through
the colocalization of receptors and specific adenylyl cyclase isoforms in lipid rafts and caveolae. The
present study sought to define the localization of key G protein-coupled receptors with adenylyl
cyclase type 6 (AC6) in lipid rafts of rat cardiac fibroblasts and to determine if this colocalization
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was functionally relevant. We found that cardiac fibroblasts produce cAMP in response to agonists
for β-adrenergic (isoproterenol), prostaglandin EP2 (butaprost), adenosine (adenosine-5′-Nethylcarboxamide, NECA), and prostacyclin (beraprost) receptors. Overexpression of AC6 increased
cAMP production stimulated by isoproterenol and beraprost but not by butaprost or NECA. A key
function of fibroblasts is the production of collagen. Isoproterenol- and beraprost-mediated inhibition
of collagen synthesis was also enhanced by AC6 overexpression, while inhibition by butaprost and
NECA were unaltered. Lipid raft fractions from cardiac fibroblasts contain the preponderance of βadrenergic receptors and AC6 but exclude EP2 receptors. While we could not determine the
localization of native prostacyclin receptors, we were able to determine that epitope-tagged
prostanoid IP receptors (IPR) expressed in COS7 cells did localize, in part, in lipid raft fractions.
These findings indicate that IP receptors are expressed in lipid rafts and can activate raft-localized
AC isoforms. AC6 is completely compartmentized in lipid raft domains where it is activated solely
by coresident G protein-coupled receptors to regulate cardiac fibroblast function.
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Cardiac remodeling, a consequence of certain cardiovascular diseases such as heart failure and
hypertension, occurs via structural rearrangement of components of myocardial wall. Such
changes include cardiomyocyte hypertrophy, cardiac fibroblast proliferation, and increased
deposition of fibrillar collagen. These responses eventually lead to cardiac fibrosis and a decline
in cardiac function (Eghbali and Weber 1990). The role of cardiac fibroblasts in these processes
is of considerable interest. In particular, strategies to limit activation of cardiac fibroblasts
could form the basis of new approaches for treating heart failure (Weber et al. 1994).
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G protein-coupled receptors (GPCRs) signal via heterotrimeric G-proteins to regulate effector
molecules and generate second messengers that activate downstream signaling. β-Adrenergic
receptors (βAR) are the most highly studied of GPCRs and they, like receptors for various
prostanoids and other hormones, couple to Gs to stimulate adenylyl cyclase (AC) activity and
generation of the second messenger 3′,5′-cyclic adenosine monophosphate (cAMP). Cardiac
fibroblasts express β2AR and various isoforms of AC, and activity of this pathway elevates
cAMP levels and inhibits fibrogenic activity of these cells (Gustafsson and Brunton 2000;
Ostrom et al. 2003; Swaney et al. 2005). The antifibrotic action of cAMP appears to be largely
due to its opposition of various aspects of transforming growth factor β signaling, including
Smad and non-Smad pathways (Liu et al. 2006). Cardiac fibroblasts produce prostacyclin
(PGI2) as their main eicosanoid product, and this factor is known to reduce cell proliferation
and collagen production (Yu et al. 1997). Because PGI2 receptors (IPR) couple to Gs and the
stimulation of AC, it is presumed that its effects on cardiac fibroblast function are mediated
through the cAMP pathway.
IPR are expressed in the vasculature (smooth muscle and endothelial cells, lymphocytes,
megakaryocytes, and platelets), kidney, and dorsal root ganglia (Narumiya et al. 1999; Bundey
and Insel 2006). PGI2 is the endogenous agonist of IPR and is a product of the cyclooxygenase
pathway, particularly that of cyclooxygenase 2 (McAdam et al. 1999). Synthetic analogs of
PGI2, including iloprost, cicaprost, and beraprost, are useful for the treatment of pulmonary
hypertension and Raynaud’s phenomenon and are being examined for their clinical usefulness
in a variety of other clinical conditions (Rubin et al. 1982; Block and Sequeira 2001; Nasrallah
and Hebert 2005).
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βAR are efficiently coupled to the activation of AC6 because of a high degree of colocalization
of these two signaling components in plasma membrane lipid rafts or caveolae (Schwencke et
al. 1999; Rybin et al. 2000; Ostrom et al. 2001; Ostrom, et al. 2002). Other GPCRs, such as
prostanoid EP2R and EP4R, are unable to couple to AC6 because of the exclusion of these
receptors from lipid rafts (Ostrom et al. 2001). Thus, colocalization of GPCR and components
of their downstream signal transduction cascade appears to be a key determinant of signaling
efficiency. However, it is less clear whether such colocalization in lipid rafts or caveolae has
an impact on the regulation of cellular function.
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Caveolae are 50–100-Å membrane invaginations enriched in the protein caveolin (Anderson
1998). Caveolae are considered a subset of lipid rafts in that both membrane regions are
enriched in sphingolipids and cholesterol and are distinct lipid environments of plasma
membrane that attract and retain certain proteins to create distinct signaling domains (Shaul et
al. 1996; Razani et al. 2002; Foster et al. 2003; Pike 2003). We and others have found that only
certain GPCR and particular AC isoforms are expressed in lipid rafts and caveolae (Ostrom et
al. 2003; Ostrom and Insel 2004). These and other similar findings have challenged the notion
that membrane-associated signaling proteins are randomly distributed in the plasma membrane
and interact via random collision coupling (Steinberg and Brunton 2001; Razani et al. 2002).
It is now readily accepted that many GPCR and their signaling partners are restricted in their
diffusion in the membrane by lipid rafts or other domains and perhaps even prearranged in
signaling complexes (Ostrom et al. 2000; Steinberg and Brunton 2001). Such a model more
easily explains how cross-talk can occur between signaling molecules of different signaling
pathways and serves to explain the compartmentation of signaling observed through various
approaches (Brunton et al. 1981; Fagan et al. 2000; Davare et al. 2001; Razani et al. 2002;
Shaul 2002).
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The present study was designed to examine the role of lipid rafts/caveolar domains in GPCR–
Gs–AC signaling and to assess if compartmentation of cAMP signaling has relevance to the
regulation of cardiac fibroblast function. We overexpressed a lipid raft localized isoform of
AC, AC6, and found that this selectively enhanced βAR signaling and did not increase the
second-messenger generation by prostanoid EP receptors. We did observe that AC6
overexpression increases response to beraprost, an agonist of IPRs. Beyond just selective
alteration of cAMP production, AC6 overexpression also enhanced the ability of βAR and IPR
to reduce collagen synthesis and myofibroblast differentiation but did not alter similar
responses mediated by prostanoid EP2 or adenosine receptors. Using COS7 cells that express
epitope-tagged IPR, we determined that IPR are expressed, in part, in lipid rafts. Thus, we
conclude that PGI2 may be an important regulator of cardiac remodeling and that the observed
compartmentation of GPCR/AC signaling in lipid rafts can have physiologically relevant
effects.

Materials and methods
Materials
Adenovirus expressing the murine AC6 complementary deoxyribonucleic acid (cDNA) was
generated as described previously (Gao et al. 1998). Primary antibodies for AC isoforms and
secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Beraprost, butaprost, and primary antibodies for EP2R and IPR were obtained from Cayman
Chemical. Forskolin was obtained from Calbiochem. Radiolabeled chemicals were obtained
from Perkin Elmer Life Sciences. All other chemicals and reagents were obtained from SigmaAldrich (St. Louis, MO).
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Cardiac fibroblasts were prepared from adult male 250–300 g Sprague–Dawley rat hearts. After
rapid excision of the hearts, the ventricles were isolated, minced, pooled, and placed in a
collagenase/pancreatin digestion solution. After sequential digestions, the fibroblasts were
pelleted and resuspended in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with penicillin, streptomycin, fungizone, and 10% fetal bovine serum (FBS, Atlanta
Biologicals). After a 30-min period of attachment to uncoated culture plates, cells that were
weakly attached or unattached were rinsed free and discarded. After 2–3 days, confluent
cultures were amplified by trypsinization and seeding onto new dishes. For signaling assays,
only early passage (≤3) cells grown to 80–90% confluency were used. The purity of these
cultures was greater than 95% cardiac fibroblasts as determined by positive staining for
vimentin and negative staining for smooth muscle actin and von Willebrand factor, as
previously described (Ostrom et al. 2003). All animals were treated according to the principles
of laboratory animal care (NIH publication no. 85-23, revised 1985) and applicable US law.
Measurement of cAMP accumulation
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Cells were washed three times with serum and NaHCO3-free DMEM supplemented with 20
mM hydroxyethyl piperazineethanesulfonic acid (HEPES), pH 7.4 (DMEH) and equilibrated
for 30 min. The assay for cAMP accumulation was performed by incubation with drugs of
interest and 0.2 mM isobutylmethylxanthine, a PDE inhibitor, for 10 min. To terminate
reactions, the assay medium was aspirated, and 200 µL lysis buffer (GE Healthcare) was added.
cAMP content of the extract was quantified using the Biotrak EIA Kit (GE Healthcare). Data
were normalized to the amount of protein per sample, as determined using a dye-binding protein
assay (Bio-Rad). In other studies, cAMP accumulation was measure using [3H]adenine
labeling as described previously (Ostrom et al. 2000). Briefly, cells were labeled with 0.5 Ci/
well [3H]adenine in the growth medium overnight to allow incorporation into intracellular
adenosine triphosphate (ATP) pools. The growth medium was removed, and cells were washed
extensively and equilibrated for 30 min at 37°C in serum-free DMEH. Cells were then
incubated for 10 min in with 200 µM isobutylmethylxanthine and various drugs of interest.
Reactions were terminated by aspiration of the medium and addition of 7.5% trichloroacetic
acid. [3H]cAMP and [3H]ATP were separated from the supernatant fraction using a
chromatography method modified from Salomon et al. and quantified by liquid scintillation
counting. Data are expressed as the percent conversion of [3H]ATP into [3H]cAMP.
Assays of collagen synthesis
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Cells were plated as described above and synchronized by incubation in serum-free DMEM
for 2 h followed by serum deprivation in Modified Eagle’s Medium (MEM) containing 0.25%
FBS for 24 h. MEM was then supplemented with 2.5% FBS (except for unstimulated
conditions, where 0.25% FBS was used) for 24 h along with 0.5 mCi of [3H]proline/well and
drugs of interest. Iso was solubilized in 2 mM ascorbic acid to prevent degradative oxidation.
The medium was removed, and the cells were washed with ice-cold phosphate-buffered saline
(PBS) and then incubated with 7.5% tricarboxylic acid (TCA) for 1 h at 4°C. TCA-precipitated
counts were determined by liquid scintillation counting.
Membrane fractionation
Cells were fractionated using a detergent-free method adapted from Song et al. (1996) and
described previously (Ostrom et al. 2001). Briefly, cells were homogenized in 500 mM sodium
carbonate plus mammalian protease inhibitor cocktail (Sigma cat# P-8340) with 20 strokes in
a Dounce homogenizer, three 10-s bursts in a tissue grinder, then three 20-s bursts with an
ultrasound cell disruptor. The homogenate was brought to 45% sucrose by addition of 90%
sucrose in 25 mM 2-N-morpholinoethanesulfonic acid, 150 mM NaCl, pH 6.5, and loaded in
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an ultracentrifuge tube. A discontinuous sucrose gradient was layered on top of the sample by
placing 2 ml 35% sucrose then 1 ml 5% sucrose. The gradient was centrifuged at 44,000 rpm
on a SW55Ti rotor (Beckman Instruments) for 16–20 h at 4°C. Fractions were collected in ten
0.5-ml aliquots from the top of the gradient. Equal volumes of fractions were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to
polyvinylidene difluoride membranes (Millipore) by electroblotting. Membranes were blocked
in PBS–Tween with 5% nonfat dry milk and incubated with primary antibody (see “Materials
and methods”) overnight at 4°C. Bound primary antibodies were visualized using an
appropriate secondary antibody with conjugated horseradish peroxidase (Santa Cruz
Biotechnology) and electrochemiluminescence reagent (Pierce). The amount of protein per
sample was determined using a dye-binding protein assay (Bio-Rad).
Immunoisolation of caveolae and measurement of AC activity
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Immunoisolation of caveolin-rich membranes were performed as described previously
(Ostrom et al. 2001). Briefly, cardiac fibroblasts were plated into 15-cm plates, grown to about
90% confluence, then starved with 0% FBS medium for 24 h. In some cases, cells were then
treated with an adenovirus expressing AC6 for 24 h. Cells were scraped and homogenized in
a modified lysis buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM ethylene
glycol tetraacetic acid [EGTA], 2 mM dithiothreitol [DTT], 0.5% Igepal CA-630, plus
mammalian protease inhibitor cocktail). Homogenate was precleared by inclubating with 50
µl protein A–agarose for 30 min at 4°C then incubated with caveolin-1 monoclonal antibody
(Pharmingen) for 1 h. Antibody complexes were then precipitated after incubation with protein
A–agarose and resuspended in membrane buffer (30 mM Na-HEPES, 5 mM MgCl2, 2 mM
DTT, pH 7.5). AC activity was conducted by adding 30 µl sample (immunoprecipitate [IP] or
supernatant) into tubes containing assay buffer (30 mM Na-HEPES, 100 mM NaCl, 1 mM
EGTA, 10 mM MgCl2, 1 mM isobutylmethylxanthine, 1 mM ATP, 10 mM phos-phocreatine,
5 µM guanosine triphosphate, 60 U/ml creatine phosphokinase, and 0.1% bovine serum
albumin, pH 7.5) and drugs of interest. Mixture was incubated for 15 min at 30°C, and reactions
were stopped by boiling for 5 min. cAMP content of each tube was assayed by using the Biotrak
EIA kit (GE Healthcare). Total protein concentration was determined using a dye-binding
protein assay (Bio-Rad), and immunoblot analysis was used to ensure the majority of
caveolin-1 was precipitated.
Immunofluorescent confocal microscopy

NIH-PA Author Manuscript

Intracellular localization of HA-IPR was visualized in COS7 cells. COS7 cells (1 × 105 cells)
were plated onto poly-L-lysine-coated glass coverslips and cultured for 24 h. Cells were then
transfected with 0.4 µg of HA-IPR (in pcDNA 3.1) cDNA using Lipofectamine (Invitrogen).
Cells were then washed with PBS (12.1 mM Na2HPO4, 4 mM KH2PO4, and 130 mM NaCl,
pH 7.4) and fixed using 4% paraformaldehyde (1 h, 20°C). After fixation, cells were washed
further in PBS and permeabilized (1 h, 20°C) with PBS containing 0.2% Triton X-100 and 1%
goat serum (blocking solution) before being incubated (12 h, 20%C) with anti-HA mAb (1:500
dilution). After further washes in PBS (3 × 10 min), cells were incubated (1 h, 20°C) with
Alexa Fluor 488 donkey anti-goat IgG in blocking solution. Coverslips were mounted in
Slowfade® light antifade (Molecular Probes) according to the manufacturer’s procedures, and
the cells were visualized on a Zeiss Axiovert LSM510 confocal microscope, using a ×63 oil
immersion objective and a slice depth of 1 µm.
Data analysis and statistics
Data are presented as the mean ± SEM and in some cases as representative images of at least
three separate experiments. Statistical comparisons (t tests and one-way analysis of variance)
and graphics were performed using GraphPad Prism 4.0 (GraphPad Software).
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We previously found that overexpression of AC6 enhances cAMP responses by receptors
colocalized in lipid rafts or caveolae without effecting responses by GPCRs in nonraft domains
(Ostrom et al. 2000; Ostrom et al. 2001; Ostrom et al. 2002). Thus, we assayed cAMP
production in response to various receptor-specific agonists in cells expressing LacZ (control)
or AC6 to infer the localization of these receptors. Adenoviruses were used to express the
desired gene, and cAMP accumulation was measured 18 h later. AC6 overexpression enhanced
forskolin-, isoproterenol-(βAR-selective agonist), and beraprost (IPR-selective agonist)mediated increases in cAMP production without a significant effect on basal cAMP
accumulation (Fig. 1). AC6 enhanced the Emax of each of these drugs without significantly
altering their EC50 (Table 1). Overexpression of AC6 did not alter response to butaprost
(EP2R-selective agonist) or adenosine-′-N-ethylcarboxamide (NECA, adenosine receptor
agonist) despite the fact that these drugs stimulated cAMP production to levels significantly
greater than basal. Thus, βAR and IPR are likely expressed in lipid rafts and caveolae of adult
rat cardiac fibroblasts along with AC6, while prostanoid EP2R and adenosine receptors are
likely excluded from these domains.
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To directly assess the localization of these natively expressed GPCRs in cardiac fibroblasts,
we isolated caveolin-rich lipid raft fractions using a detergent-free method followed by sucrose
density centrifugation. We previously detected expression of AC2, AC3, AC4, AC5/6, and
AC7 in adult rat cardiac fibroblasts, with AC3 being the most readily detectible isoform
(Ostrom et al. 2003). Immunoblot analysis confirmed the expression of predominantly AC3
in lipid raft fractions along with faint bands corresponding to AC5/6 (Fig. 2). Several bands
were observed on immunoblots for β2AR, AC3, and AC5/6 (Fig. 2, right panels). The primary
antibodies for β2AR and the various AC isoforms available from Santa Cruz Biotechnology
often yield many nonspecific bands and smears the size of which vary by cell type. However,
the lipid raft fractionation procedure can yield samples that, when heavily loaded on SDSPAGE gels and probed with antibodies diluted by a 1:500 ratio, produce interpretable
immunoblots. We identified the appropriate bands in these blots by overexpressing AC6 using
an adenovirus (Fig. 2, left panels) or by transiently transfecting β2AR or AC3 in COS7 cells
(data not shown). The buoyant, lipid raft fractions contained the vast majority of caveolin-1
immunoreactivity (bottom panel) but excluded markers for Golgi (mannosidase II) or clathrincoated pits (β-adaptin, not shown). Adenoviral treatment of cells to overexpress AC6 led to
distinct AC5/6 immunoreactive bands in the lipid raft fractions. We also detected expression
of β2AR in lipid raft fractions, consistent with previous reports from other cell types (Ostrom
et al. 2000; Rybin et al. 2000; Ostrom et al. 2002). By contrast, EP2R immunoreactivity was
completely excluded from the lipid raft factions. We were unable to detect the endogenous
expression of either IPR or adenosine receptors using commercially available antibodies.
To confirm the localization of endogenous GPCRs and AC6 with respect to lipid rafts and
caveolae of cardiac fibroblasts, we used a different approach to isolate these domains and
assayed for agonist-stimulated activity of AC. Immunoisolation of caveolae from detergentsolubilized cardiac fibroblasts was achieved using antibodies to caveolin-1 (see “Materials and
methods”). This modified immunoprecipitation of caveolin-1 trapped the bulk of the caveolin-1
and AC5/6 immunoreactivity (Fig. 3, top panels) along with the majority of cholesterol (not
shown). AC activity assays were then measured in caveolin-1 IPs or the supernatants from cells
expressing either LacZ (control) or AC6. AC6 overexpression enhanced the AC activity in the
IPs stimulated by forskolin, isoproterenol, and beraprost (Fig. 3 and Table 2). By contrast, AC
activity stimulated by butaprost was not higher in caveolin-1 IPs but was slightly elevated in
the supernatants. These data indicate that immunoisolated caveolae contain functional units of
AC6 coupled to βAR and IPR but not to EP2R, consistent with our observations shown in Fig.

Naunyn Schmiedebergs Arch Pharmacol. Author manuscript; available in PMC 2009 June 1.

Liu et al.

Page 7

2. These data also imply that a small amount of AC6 may couple to EP2R in the supernatants
left behind from the immunoisolation of caveolae.
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To determine if IP receptors localize in lipid raft fractions of mammalian cells, we transiently
transfected the human IPR gene fused with an HA epitope into COS7 cells and assessed (1)
cAMP production in response to beraprost and (2) the localization of the epitope in lipid raft
fractions and intact cells. Mock transfected COS7 cells did not produce cAMP in response to
beraprost, indicating that these cells do not express IPR (data not shown). Transfection of HAIPR into control COS-7 cells led to detectable cAMP production in response to beraprost (−log
EC50=7.42±0.11 and Emax=3.6-fold over basal, Fig. 4a). Over-expression of AC6 in IPRexpressing COS-7 cells led to an increase in Emax with no shift in EC50 (−log EC50=7.40±0.16
and Emax=8.9-fold over basal). AC6-overexpressing COS7 cells responded to a submaximal
concentration of forskolin (1 µM) with a 12.8±0.57-fold increase over basal cAMP production.
Thus, the expression of HA-IPR in COS7 cells appears to be a reasonable model for studying
the localization and function of IPR in cardiac fibroblasts.
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To directly assess the localization of IPR in COS7 cells, we transfected the HA-IPR construct
and performed immunofluorecent microscopy and isolated lipid raft fractions using the same
method as above (Fig. 2). Immunofluorescence microscopy of untreated cells shows that much
of the HA epitope is expressed in intercellular domains with less fluorescence at the plasma
membrane of most cells (Fig. 4b, right panel). These observations are consistent with a majority
of the HA-IPR protein being retained in the endoplasmic reticulum or Golgi and lower levels
of the receptor reaching the plasma membrane. Detergent-free isolation of lipid raft fractions
followed by sucrose density centrifugation show that a majority of the HA-IPR
immunoreactivity appears in heavy fractions, consistent with our microscopic findings.
However, a distinct portion of HA-IPR immunoreactivity is detectible in caveolin-rich, lipid
raft fractions (Fig. 4b, left panels). To determine if agonist activation alters the subcellular
localization of IPR, we treated cells with 1 µM beraprost for 10 min before fixing cells for
microscopy or lysing for lipid raft fractionation. Beraprost treatment did not significantly alter
the distribution of HA immunofluorescence (Fig. 4b, bottom). Agonist treatment did cause a
shift of HA immunoreactivity from fractions 8–9 to fractions 6–7 on the sucrose density
gradients but did not alter the proportion of immunoreactivity observed in the buoyant lipid
raft fractions (3–4). Therefore, IPR appear to be expressed, in part, in lipid rafts, and agonist
activation does not significantly increase or decrease the proportion of this receptor in lipid
rafts. Previous studies indicate that IPR do not undergo densensitization (Hasse et al. 2003).
While our observations imply that IPR also do not significantly translocate into or out of lipid
rafts, more studies are needed to confirm if these receptors translocate or internalize in other
ways.
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We sought to extend our observations of GPCR–AC6 compartmentation to a functional
response in cardiac fibroblasts. Previous studies indicate that cAMP-elevating agents and AC6
overexpression can inhibit collagen production and myofibroblast differentiation of cardiac
and other fibroblasts (Liu et al. 2004; Swaney et al. 2005; Liu et al. 2006). Thus, we assessed
proline incorporation as a measure of total collagen synthesis. Forskolin, isoproterenol,
beraprost, and butaprost each inhibited proline incorporation stimulated by 2.5% FBS in a
concentration-dependent manner (Fig. 5). Beraprost and butaprost only induced significant
levels of inhibition at the highest concentrations used (10 µM), while forskolin and
isoproterenol caused inhibition at lower concentrations. NEC A also significantly (p<0.05 by
paired t test) inhibited serum-stimulated proline incorporation at higher concentrations (NECA
16±3.2% inhibition). Therefore, each of the agents that elevated cAMP production (Fig. 1) was
able to inhibit proline incorporation.
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We then compared the percent inhibition of proline incorporation by a maximal concentration
of each drug in LacZ (control) and AC6-overexpressing cells. AC6 over-expression reduced
FBS-stimulated proline incorporation and enhanced the responses to forskolin, isoproterenol,
and beraprost (Fig. 6a). By contrast, the inhibition of proline incorporations by either butaprost
or NECA was unaltered in AC6-overexpressing cells. Viewing this same data transformed as
percent inhibition (where the level of proline incorporation stimulated by 2.5% FBS represents
0% inhibition and the basal level of incorporation is 100% inhibition) makes clear that the level
of inhibition that stimulated forskolin, isoproterenol, and beraprost is enhanced by AC6
overexpression (Fig. 6b). The percent inhibition by forskolin in AC6-overexpressing cells was
greater than 100%, indicating that this condition reduced levels of proline incorporation to
levels below that of basal (0% serum). Thus, while EP2R and adenosine receptors may be
capable of stimulating cAMP production and regulating fibroblast function, these receptors do
not signal via the lipid raft-localized AC6 to stimulate cAMP production or inhibit collagen
synthesis. Only receptors colocalized with AC6 (βAR and IPR) appear to utilize the
overexpressed AC to enhance their regulation of cell function.

Discussion
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The rapidity of GPCR signal transduction defies the relative low abundance of GPCR and the
multiple other proteins (G proteins, ACs, etc.) involved in the signaling mechanism. Moreover,
most mammalian cells express 20–30 different GPCRs that couple to just five different classes
of G proteins. This equates to at least four or five different GPCRs in a single cell sharing the
same signal transduction pathway. It would be overly simplistic to propose that each of these
GPCRs, some of which might respond to neuro-transmitters, some to circulating hormones,
and others to local peptide signals, have identical effects on cell function. For these reasons, a
more complex model that incorporates some degree of compartmentation of GPCR signaling
is more satisfying from a teleological perspective.
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In adult rat cardiac fibroblasts, we find that AC6 overexpression selectively enhances both
proximal signaling events and downstream alterations in cell function by βAR and IPR over
other receptors coupled to the same pathway. Specifically, AC6 overexpression increased the
maximal cAMP production in response to isoproterenol (βAR) and beraprost (IPR) but did not
alter responses to butaprost (EP2R) or NECA (adenosine receptors). These results are
consistent with our observations in other cell types (Ostrom et al. 2000; Ostrom et al. 2001;
Ostrom et al. 2002). However, we also find that this same pattern of enhanced effects extends
to a key regulatory action of the cAMP pathway in cardiac fibroblasts: the inhibition of collagen
production. Our studies of lipid raft fractions from cardiac fibroblasts and COS-7 cells
expressing HA-IPR, along with immunoisolated caveolar membranes from cardiac fibroblasts,
demonstrate that AC6 is colocalized with βAR and IPR but not with EP2R. These results show
that GPCR–AC signaling is highly compartmentized in cardiac fibroblasts and that responses
mediated by specific receptors can be enhanced by overexpression of a particular AC isoform.
Consistent with the present findings, Swaney et al. (2005) previously reported that AC6
overexpression enhances forskolin-mediated inhibition of myofibroblast transformation and
collagen synthesis. These investigators also reported that AC6 overexpression uncovered an
inhibition of cardiac fibroblast function by adrenomedullin. Thus, one would speculate that
adrenomedullin/calcitonin gene-related peptide receptors are expressed at low levels in lipid
rafts of cardiac fibroblasts such that when the colocalized AC6 is overexpressed, the receptors
are able to stimulate cAMP to levels sufficient for inhibiting cell function.
Our findings that PGI2 can regulate cardiac fibroblast collagen production are not novel. Yu
et al. (1997) described that cardiac fibroblasts from Wistar–Kyoto and spontaneously
hypertensive rats produce and respond to PGI2. It is interesting to note that these investigators
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found that cells isolated from spontaneously hypertensive rats produced less PGI2 and, thus,
proposed that this lower eicosenoid production could account for the increased fibrosis of
hypertensive rats. Increasing expression of AC6 in cardiac fibroblasts could lead to an
abrogation of this defect in hypertensive rats by inducing a larger response to the decreased
level of IPR activation. Studies to directly test this idea have yet to be performed.
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Our studies of epitope-tagged IPR expressed in COS7 cells directly demonstrate that IPR is
expressed, at least in part, in caveolae and/or lipid rafts. We detected a small proportion of HAIPR in lipid raft fractions from COS-7 cells but also determined that a large majority of the
receptor expression under these conditions is not plasma membrane localized. Instead, the
exogenously expressed receptor appears to be expressed in intracellular stores, perhaps because
of high levels of expression. Despite this limitation, our data regarding signaling and function
of IPR in cardiac fibroblasts are consistent with the hypothesis that these receptors are localized
in lipid rafts. First, responses to beraprost are enhanced by expression of AC6, which is
localized completely in lipid raft fractions. Second, beraprost was able to stimulate AC activity
in immunoisolated caveolae but not in the supernatants left behind from these isolations (which
did contain butaprost-mediated stimulation of AC activity). Taken together, these data indicate
that natively expressed IPR reside largely in lipid rafts. Consistent with this idea, Bundey and
Insel (2006) recently describe that in human umbilical vein endothelial cells, AC6
overexpression preferentially enhances PGI2-stimulated responses. They measured both
cAMP production in response to beraprost and beraprost-mediated inhibition of thrombinstimulated endothelial cell barrier function. Thus, the data imply that native IPR are also
expressed largely in lipid raft domains of endothelial cells where these receptors can couple
efficiently to AC6.
The fact that agonists for nonraft GPCRs can increase cAMP production and inhibit collagen
production seemingly implies that cAMP action is not highly compartmentized in cardiac
fibroblasts. While this may be true, it may also be a factor of the long-term stimulation of cAMP
levels that is required for observing effects on collagen gene expression. Studies that have
directly demonstrated compartmentation of cAMP signaling in other cells have focused on
rapid responses to AC activation (Davare et al. 2001). Thus, cardiac fibroblasts may still have
discreet compartments of cAMP generation when stimulation times are transient but that these
compartmentizing mechanisms are overcome by hour-long activation. Alternatively, different
cAMP compartments may exist for certain functions, but these different pools converge to
regulate other consequences, such as the regulation of collagen gene expression. These ideas
need further exploration using new, innovative research tools.
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Our findings indicate that GPCR/AC signaling is compartmentized in lipid rafts of cardiac
fibroblasts such that certain receptors couple selectively to AC6. We and others have shown
that AC isoforms display discrete isoform-specific localization with respect to lipid rafts (Smith
et al. 2002; Ostrom et al. 2003). AC3, AC5/6, and AC8 are characteristically localized in lipid
rafts, while other isoforms are excluded from these domains. Thus, it would be expected that
nonraft GPCR would couple selectively to nonraft isoforms of AC. While this idea has not
been directly tested, it is intriguing to note that Gros et al. (2006) overexpressed AC1, AC2
AC5, and AC6 in vascular smooth muscle cells and found that different cellular responses
(such as cell proliferation and cytoskeletal reorganization) were selectively enhanced by
different ACs. Such results imply that different AC isoforms participate in discreet signaling
complexes that can contain different partners to achieve heterogeneity of signaling properties
(Cooper 2003).
In conclusion, our findings further the idea that GPCR exist in functional compartments such
that receptors for very diverse extracellular signals can elicit heterogeneous cellular responses
despite their utilizing redundant signal transduction mechanisms. GPCRs that increase cAMP
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production in cardiac fibroblasts can inhibit activation of these cells, and AC overexpression
can enhance these effects if there is colocalization between the receptor and the AC. These
results provide the impetus to test if therapies that enhance signaling via the AC/cAMP/PKA
pathway, such as overexpression of AC, can limit the development of cardiac fibrosis in various
models of cardiovascular disease.

Abbreviations
AC, Adenylyl cyclase; βAR, β-Adrenergic receptor; cAMP, 3′,5′-Cyclic adenosine
monophosphate; Fsk, Forskolin; Iso, Isoproterenol PKA; PGE2, Prostaglandin E2; IPR,
Prostanoid IP receptor.
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Fig. 1.
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cAMP production stimulated by certain GPCR is enhanced by overexpression of AC6. cAMP
production was measured in cells incubated with either LacZ- or AC6-expressing recombinant
adenovirus for 24 h. Cells were incubated with the indicated drugs along with a
phosphodiesterase inhibitor for 10 min at 37°C before cells were lysed and cAMP content
assayed by EIA (see “Materials and methods”). Each bar represents the mean±SEM of at least
three experiments. Asterisk denotes p<0.05, double asterisk denotes p<0.01 as compared to
the same condition in LacZ cells, and number sign denotes p<0.05 as compared to basal by
ANOVA
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Fig. 2.

Localization of GPCRs and ACs in lipid raft fractions from rat cardiac fibroblasts. Expression
of caveolin-1, AC3, AC5/6, β2AR, and EP2R was assessed by SDS-PAGE and immunoblot
analysis of buoyant (cav) and “heavy” (non-cav) membrane fractions and whole-cell lysates
(WCL) from cardiac fibroblasts isolated using a nondetergent method followed by sucrose
density centrifugation. Fractions from cells overexpressing AC6 (using a recombinant
adenovirus) were also analyzed for AC5/6 immunoreactivity. Cav samples were pooled from
the fractions at the 5–35% sucrose interface while the non-cav samples were pooled from the
fractions in the 45% sucrose layer. Equal volumes of each fraction were loaded to represent
the relative proportions of protein as they exist in intact cells. Right panels show full-length
immunoblots probed with AC3 and AC5/6 antibodies. Images are representative of at least
three experiments
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Fig. 3.

βAR and IPR but not EP2R stimulate AC activity in immunoisolated caveolae. Caveolin-1
antibodies were used to immunoprecipitate caveolar fractions isolated by Triton-X100
insolubility. Precipitates and supernatants were assayed for AC activity as described in
“Materials and methods.” Caveolin-1 immunoprecipitates contained the bulk of caveolin-1 and
AC5/6 immunoreactivity while the supernatants contained very little caveolin-1 and less AC5/6
(top panels). Forskolin (Fsk), isoproterenol (Iso), and beraprost-stimulated AC activities in the
IPs were enhanced by AC6 overexpression while butaprost-stimulated AC activity was
unaffected (bottom panel). Data are expressed as the fold increase induced by AC6
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overexpression (raw data is shown in Table 2). Asterisk denotes p<0.05, and double asterisk
denotes p<0.01 as compared to 1 (no increase over control) by ANOVA
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Fig. 4.

HA-IPR are detected in lipid raft fractions and intracellular stores in COS-7 cells. a cAMP
production was measured using [3H]adenine labeling in COS-7 cells transiently transfected
with an HA-tagged IPR construct. Responses to forskolin or various concentrations of
beraprost were compared in cells treated with recombinant adenovirus expressing either LacZ
(control) or AC6. Each bar or point represents the mean±SEM of at least three experiments.
Asterisk denotes p<0.05, double asterisk denotes p<0.01 as compared to the same condition in
LacZ cells, and number sign denotes p<0.05 as compared to basal by ANOVA. b COS7 cells
transiently transfected with HA-IPR were fractionated using a nondetergent method and
analyzed by SDS-PAGE and immunoblotting (left panels) or fixed and visualized by
immunofluorescent microscopy (right panels). Much HA-IPR is detected in intracellular stores
and “heavy” fractions, but a portion is detected in the plasma membrane and buoyant lipid raft
fractions coexpressing caveolin-1. Images are representative of at least three experiments
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Fig. 5.

cAMP-elevating agents inhibit collagen synthesis in rat cardiac fibroblasts. [3H]Proline
incorporation stimulated by 2.5% FBS was measured in the absence or presence of increasing
concentrations of forskolin (a), isoproterenol (b), beraprost (c), or butaprost (d). Cells were
serum deprived for 24 h and then treated with the indicated drug for 20 min before addition of
2.5% FBS for another 48 h (see “Materials and methods”). Each bar or point represents the
mean±SEM of at least three experiments. Asterisk denotes p<0.05 as compared to 2.5% FBS,
and number sign denotes p<0.05 as compared to 0.25% FBS (basal) by ANOVA
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Fig. 6.

AC6 overexpression enhances the inhibition of collagen synthesis mediated by βAR and IPR
but not EP2R or adenosine receptors. [3H]Proline incorporation stimulated by 2.5% FBS was
measured in the absence or presence of forskolin, isoproterenol, beraprost, butaprost, or NECA.
Cells were serum deprived for 24 h and then treated with the indicated drug for 20 min before
addition of 2.5% FBS for another 48 h (see “Materials and methods”). Data are expressed as
the total incorporated proline counts (a) or as the percent inhibition of the FBS-stimulated
proline incorporation (b, forskolin inhibits greater than 100% in the AC6 conditions because
it induces a level of incorporation that is less than the 0% FBS condition). Each bar represents
the mean±SEM of at least three experiments. Asterisk denotes p<0.05 as compared to the LacZ
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condition, and number sign denotes p<0.05 as compared to 2.5% FBS (0% inhibition) by
ANOVA
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Table 1

EC50 values and maximal responses (Emax, pmol cAMP/mg protein) to various Gs-coupled receptor agonists for cAMP
production in LacZ- (control) and AC6-overexpressing cells
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Drug

LacZ (control)

AC6

−log (EC50)

Emax

−log (EC50)

Emax

Forskolin

4.65±0.16

10.21±1.19a

4.41 ±0.30

37.68±3.79a

Isoproterenol

7.44±0.29

3.49±0.53

7.62±0.04

8.63±0.21

Beraprost

6.72±0.09

1.87±0.14

6.18±0.07

8.90±0.30

Butaprost

7.31±0.14

1.79±0.22

7.29±0.08

1.81±0.04

NECA

6.19±0.24

1.10±0.05

6.21±0.19

1.13±0.11

Adenoviruses were used to overexpress each gene product. Values are presented as mean±SEM of at least three experiments. Basal levels of cAMP
production were not significantly different (LacZ-expressing cells=0.24±0.09 pmol/mg protein, AC6-overexpressing cells=0.45±0.1 pmol/mg protein).
a

Emax fixed to observed maximum response to obtain fit of the data by nonlinear regression
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Table 2

Adenylyl cyclase activity stimulated by various drugs in immunoisolated caveolar membranes isolated from LacZ(control) and AC6-overexpressing rat cardiac fibroblasts
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Drug

LacZ (control)

AC6

IP

Sup

IP

Sup

Basal (no drug)

0.62±0.08

0.29±0.11

0.70±0.12

0.27±0.10

Forskolin (10 µM)

1.43±0.25*

0.57±0.18*

5.18±0.36*,**

1.03±0.29*,**

Isoproterenol (1 µM)

0.94±0.12*

0.42±0.09*

2.98±0.41*,**

0.49±0.08*

Beraprost (1 µM)

0.86±0.13*

0.34±0.10

1.76±0.20*,**

0.30±0.12

Butaprost (1 µM)

0.59±0.17

0.40±0.06

0.64±0.05

0.56±0.07**

Adenoviruses were used to overexpress each gene product. Values are pmol cAMP min−1 mg protein−1 (mean±SEM of at least three experiments).
Transformed version of this data is shown in Fig. 3.
*

p<0.05 as compared to basal by ANOVA.

**

p<0.05 as compared to LacZ cells by ANOVA
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